Birgitte Bjornhart
Sdr. Boulevard 29
Odense, 5000, Denmark
Odense, 5000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 22, 2026
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 03, 2023
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
Journal: Thrombosis research
Published: August 02, 2022
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.
Journal: Cancers
Published: March 09, 2022
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 11, 2022
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Journal: Cancers
Published: August 27, 2021
Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 14, 2019
Dermatomyositis as a paraneoplastic first symptom of ovarian cancer
Journal: Ugeskrift for laeger
Published: February 23, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026